Oncology

The new study found an 80% increase in cancer among people under 50 over the last three decades. Screening and prevention programs for early-onset cancer may be worth exploring.

An immune response was seen in half of participants in a phase I clinical trial

Some of the categories with those most likely to have this type of cancer might be unexpected.

Alprazolam may be the safer choice.

Health Canada has conditionally approved Lynparza (olaparib) in combination with abiraterone and prednisone or prednisolone.

Body fat composition also more altered in patients getting chemotherapy compared to hormone treatment.

The study, published Monday in the journal Cancer, looked at prostate cancer screening data among almost 1.5 million men in Alberta between 2014 and 2022.

Test developed by researchers in Quebec has caught interest of World Health Organization.